IRIS
ROSSI, Davide
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.804
EU - Europa 10.977
AS - Asia 6.620
SA - Sud America 1.401
Continente sconosciuto - Info sul continente non disponibili 408
AF - Africa 134
OC - Oceania 8
Totale 32.352
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.466
RU - Federazione Russa 2.902
IE - Irlanda 2.608
SG - Singapore 1.797
CN - Cina 1.746
HK - Hong Kong 1.410
DE - Germania 1.358
BR - Brasile 1.058
UA - Ucraina 1.036
SE - Svezia 965
VN - Vietnam 834
FI - Finlandia 603
IT - Italia 538
FR - Francia 406
GB - Regno Unito 263
IN - India 231
CA - Canada 164
AR - Argentina 147
BD - Bangladesh 130
KR - Corea 96
MX - Messico 78
ID - Indonesia 59
ZA - Sudafrica 55
EC - Ecuador 52
JP - Giappone 50
PL - Polonia 50
CO - Colombia 48
IQ - Iraq 41
NL - Olanda 40
EU - Europa 38
IR - Iran 37
TR - Turchia 33
ES - Italia 31
PY - Paraguay 31
VE - Venezuela 31
AT - Austria 29
BE - Belgio 26
CZ - Repubblica Ceca 24
JM - Giamaica 20
PK - Pakistan 20
LT - Lituania 19
CL - Cile 15
MA - Marocco 15
CR - Costa Rica 14
UZ - Uzbekistan 14
PH - Filippine 13
EG - Egitto 12
HN - Honduras 12
MD - Moldavia 12
TT - Trinidad e Tobago 12
EE - Estonia 11
KE - Kenya 11
SA - Arabia Saudita 11
IL - Israele 10
MY - Malesia 10
RO - Romania 10
TW - Taiwan 10
CH - Svizzera 8
DZ - Algeria 8
OM - Oman 8
DK - Danimarca 7
GT - Guatemala 7
PE - Perù 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
BG - Bulgaria 6
KZ - Kazakistan 6
TN - Tunisia 6
AU - Australia 5
AZ - Azerbaigian 5
BJ - Benin 5
ET - Etiopia 5
GR - Grecia 5
HR - Croazia 5
NI - Nicaragua 5
PR - Porto Rico 5
TH - Thailandia 5
BB - Barbados 4
KG - Kirghizistan 4
LB - Libano 4
NP - Nepal 4
PA - Panama 4
SN - Senegal 4
SY - Repubblica araba siriana 4
AM - Armenia 3
BH - Bahrain 3
BS - Bahamas 3
CY - Cipro 3
DO - Repubblica Dominicana 3
MN - Mongolia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CW - ???statistics.table.value.countryCode.CW??? 2
GY - Guiana 2
HT - Haiti 2
JO - Giordania 2
Totale 31.953
Salva come PNG Salva come JPEG
Città #
Dublin 2.607
Jacksonville 1.906
Hong Kong 1.408
San Jose 1.224
Dearborn 1.008
Singapore 727
Wilmington 701
Council Bluffs 627
Ashburn 608
Beijing 511
Moscow 382
Chandler 381
Princeton 341
Lawrence 339
Ho Chi Minh City 293
Lauterbourg 290
Los Angeles 260
San Mateo 256
Hanoi 185
Andover 177
Buffalo 169
Ann Arbor 167
Phoenix 166
Santa Clara 161
Piemonte 146
New York 125
Columbus 123
São Paulo 104
Boardman 92
Seoul 90
Dallas 89
Houston 86
Hefei 80
Nanjing 72
Redondo Beach 71
Orem 69
Kunming 65
Woodbridge 65
Guangzhou 64
Frankfurt am Main 56
Atlanta 54
Munich 50
Montreal 48
Bremen 47
Norwalk 45
Tokyo 43
Toronto 43
Chicago 41
Novara 41
Rio de Janeiro 40
Warsaw 40
Denver 39
Milan 37
Mexico City 36
London 35
Seattle 35
Tianjin 35
Chennai 34
Helsinki 34
Da Nang 33
Grafing 32
Hangzhou 32
Jinan 32
Düsseldorf 31
Nuremberg 30
Haiphong 27
Brooklyn 26
Nanchang 26
Belo Horizonte 25
Las Vegas 24
Poplar 24
Brussels 23
Shanghai 23
Stockholm 23
Johannesburg 22
San Francisco 22
Brasília 20
Fairfield 20
North Bergen 20
Guayaquil 19
Rome 19
Amsterdam 18
Biên Hòa 18
Boston 18
Manchester 18
Thái Bình 18
Zanjan 18
Brno 17
Curitiba 17
Dhaka 17
Florence 17
Mumbai 17
Ninh Bình 17
Queens 17
Turku 17
Fuzhou 16
Philadelphia 16
Shenyang 15
Vercelli 15
Asunción 14
Totale 17.941
Salva come PNG Salva come JPEG
Nome #
Molecular clustering on ctDNA improves the prognostic stratification of DLBCL patients compared to ctDNA levels 192
Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia 187
Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis 185
Analysis of human beta papillomavirus and Merkel cell polyomavirus infection in skin lesions and eyebrow hair bulbs from a cohort of chronic lymphocytic leukaemia patients. 183
Diffuse large B-cell lymphoma genotyping on the liquid biopsy 178
International Prognostic Score for Asymptomatic Early-stage Chronic Lymphocytic Leukemia 169
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia 165
Alteration of BIRC3 and multiple other NF-kB pathway genes in splenic marginal zone lymphoma 162
The krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. 157
Bendamustine and subcutaneous Alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients. 153
Molecular lesions of signalling pathway genes in clonal B-cell lymphocytosis with marginal zone features. 153
CLINICAL IMPACT OF SMALL SUBCLONES HARBORING NOTCH1, SF3B1 OR BIRC3 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 152
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation 151
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas 151
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development 150
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia 149
NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment. 149
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. 149
Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials 148
Beta-HPV infection and skin cancer in patients suffering from chronic lymphocytic leukemia. 148
CLINICAL IMPLICATIONS OF THE MOLECULAR GENETICS OF CHRONIC LYMPHOCYTIC LEUKEMIA 148
CLINICAL IMPACT OF SMALL TP53 MUTATED SUBCLONES IN CHRONIC LYMPHOCYTIC LEUKEMIA 147
Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome 146
ASSOCIATION BETWEEN MOLECULAR LESIONS AND SPECIFIC B-CELL RECEPTOR SUBSETS IN CHRONIC LYMPHOCYTIC LEUKEMIA 146
Active AKT signaling triggers CLL towards Richter's transformation via over-activation of Notch1 146
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome 142
Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma 141
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up 141
The clinical implications of gene mutations in chronic lymphocytic leukaemia 140
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study 139
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia 139
The genetics of nodal marginal zone lymphoma 138
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild type chronic lymphocytic leukemia 137
Absence of NOTCH1 gene mutations in MALT lymphomas 136
A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment 136
Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphoma 134
Extra-osseous Ewing sarcoma of the thyroid gland mimicking lymphoma recurrence: a case report 133
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness 132
Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naïve patients with chronic lymphocytic leukemia 132
A leukemia-protective germline variant mediates chromatin module formation via transcription factor nucleation 132
Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders 131
GENETIC LESIONS ASSOCIATED WITH CHRONIC LYMPHOCYTIC LEUKEMIA CHEMO-REFRACTORINESS 131
Biology and treatment of Richter syndrome 131
Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21 130
MOLECULAR BASES OF CHRONIC LYMPHOCYTIC LEUKEMIA IN LIGHT OF NEW TREATMENTS 130
Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma 130
Analysis of NOTCH1 mutations in monoclonal B cell lymphocytosis 129
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia 129
Beta-HPV infection and skin cancer in patients suffering from chronic lymphocytic leukemia. 128
MOLECULAR BASIS OF TARGET THERAPY FOR AGGRESSIVE B-CELL LYMPHOMA 128
Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia 126
Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma 126
Analysis of immunoglobulin heavy and light chain variable genes in post-transplant lymfoproliferative disorders 126
Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia 126
MYC NETWORK MUTATIONS IN HIGH-RISK CHRONIC LYMPHOCYTIC LEUKAEMIA 125
Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma 125
Lymphocyte doubling time in chronic lymphocytic leukemia modern era: a real-life study in 848 unselected patients 124
ALTERAZIONI GENETICHE E INTERAZIONI CON IL MICROAMBIENTE NEI LINFOMI MALIGNI 123
14q32 Translocations and risk of Richter transformation in chronic lymphocytic leukaemia 123
Genetic Landscape of Ultra-Stable Chronic Lymphocytic Leukemia Patients 123
Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome 123
Recurrent mutations refine prognosis in chronic lymphocytic leukemia. 122
BCL2 MUTATION SPECTRUM IN B-CELL NON-HODGKIN LYMPHOMAS AND PATTERNS ASSOCIATED WITH EVOLUTION OF FOLLICULAR LYMPHOMA 121
AGGIORNAMENTI DI PATOGENESI MOLECOLARE DEI LINFOMI HIV-CORRELATI 121
Clinical significance of c.7544-7545 delCT NOTCH1 mutation in chronic lymphocytic leukaemia 121
Clues to the pathogenesis of Waldenström Macroglobulinemia and IgM-MGUS provided by the analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors 120
Circulating tumor DNA reveals genetics, clonal evolution and residual disease in classical Hodgkin lymphoma 117
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL 116
Simian Virus 40 (SV40) infection in lymphoproliferative disorders: A reappraisal based on five hundred cases 115
Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia 115
Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukemia 115
Ibrutinib-naïve chronic lymphocytic leukemia lacks Bruton tyrosine kinase mutations associated with treatment resistance. 115
The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation 115
Genetic and phenotypic attributes of splenic marginal zone lymphoma 115
Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease. 113
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study 113
Beta-2-microglobulin is an independent predictor of progression in asymptomatic multiple myeloma 112
Simultaneous diagnosis of CD3+ T-cell large granular lymphocyte leukaemia and true thymic hyperplasia 112
Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia 112
Late relapse in patients with diffuse large B-cell lymphoma: impact of rituximab on their incidence and outcome 112
NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-κB pathways 111
Cryoglobulin-induced IL-1 beta gene expression and procytokine in monocytes from cryoglobulinemic patients. 110
HBV AND LYMPHOMAGENESIS: NOVEL INSIGHTS INTO AN OCCULT RELATIONSHIP 110
Renal handling of monoclonal free light chains depends on fractional excretion: study on 1039 serum-urine paired samples of 187 patients 110
The PD-1/PD-L1 axis contributes to T cell dysfunction in chronic lymphocytic leukemia 110
HIF-1α is overexpressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia 110
CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression 110
Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations 110
Italian external and multicentric validation of the MD Anderson Cancer Center nomogram and prognostic index for chronic lymphocytic leukaemia patients: analysis of 1502 cases. 109
The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment 109
RICHTER SYNDROME: FROM MOLECULAR GENETIC TO THERAPEUTIC STRATEGIES 109
Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: A retrospective survey of 50 patients 108
GENETIC ABERRATIONS OF SIGNALING PATHWAYS IN LYMPHOMAGENESIS: REVELATIONS FROM NEXT GENERATION SEQUENCING STUDIES 108
A PHASE II MULTI-CENTER TRIAL OF PENTOSTATIN PLUS CYCLOPHOSPHAMIDE WITH OFATUMUMAB IN OLDER PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS 108
Mutations in the 3′ untranslated region of NOTCH1 are associated with low CD20 expression levels in chronic lymphocytic leukemia 108
Analysis of the coding genome of diffuse large B-cell lymphoma 108
XPO1 mutations identify early‐stage CLL characterized by shorter time to first treatment and enhanced BCR signalling 107
Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi 107
ASSOCIATION BETWEEN GENE AND MIRNA EXPRESSION PROFILES AND STEREOTYPED SUBSET #4 B-CELL RECEPTOR IN CHRONIC LYMPHOCYTIC LEUKEMIA. 106
Saliva is a reliable and practical source of germline DNA for genome-wide studies in chronic lymphocytic leukemia 106
Totale 13.059
Salva come PNG Salva come JPEG
Categoria #
all - tutte 168.117
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 168.117
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.639 0 0 0 193 154 15 209 31 154 57 363 463
2022/20234.202 356 132 213 60 154 321 98 177 2.532 5 95 59
2023/20241.217 74 68 82 22 238 15 256 29 5 5 81 342
2024/20253.295 63 10 68 40 93 218 279 246 1.221 418 103 536
2025/202611.064 425 392 1.002 1.744 753 776 1.646 1.916 853 835 558 164
2026/20272.887 424 801 934 728 0 0 0 0 0 0 0 0
Totale 32.352